2-Pyrazoline






12 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 15509163 4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships. J Med Chem 2004 Nov 4 2
2 18325637 Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). Eur J Med Chem 2008 Nov 1
3 22336385 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence. Eur J Med Chem 2012 Apr 1
4 22512552 Melatonin synthetic analogs as nitric oxide synthase inhibitors. Mini Rev Med Chem 2012 Jun 1
5 22583669 Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors. Bioorg Med Chem 2012 Jun 15 2
6 22985957 Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. Bioorg Med Chem 2012 Oct 15 2
7 22985962 Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase. Bioorg Med Chem 2012 Oct 15 3
8 23735830 Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group. Bioorg Med Chem 2013 Jul 15 4
9 25496804 Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors. Bioorg Med Chem 2015 Jan 1 2
10 25541201 Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors. Bioorg Med Chem 2015 Feb 1 2
11 26293971 Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives. Arch Pharm (Weinheim) 2015 Oct 1
12 28676270 Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis. Bioorg Med Chem Lett 2017 Aug 15 1